Literature DB >> 19667113

A common variant in low-density lipoprotein receptor-related protein 6 gene (LRP6) is associated with LDL-cholesterol.

Maciej Tomaszewski1, Fadi J Charchar, Timothy Barnes, Magdalena Gawron-Kiszka, Agnieszka Sedkowska, Ewa Podolecka, Jacek Kowalczyk, Wendy Rathbone, Zbigniew Kalarus, Wladyslaw Grzeszczak, Alison H Goodall, Nilesh J Samani, Ewa Zukowska-Szczechowska.   

Abstract

OBJECTIVE: A rare mutation in low-density lipoprotein receptor-related protein 6 gene (LRP6) was identified as the primary molecular defect underlying monogenic form of coronary artery disease. We hypothesized that common variants in LRP6 could predispose subjects to elevated LDL-cholesterol (LDL-C). METHODS AND
RESULTS: Twelve common (minor allele frequency > or =0.1) single nucleotide polymorphisms in LRP6 were genotyped in 703 individuals from 213 Polish pedigrees (Silesian Cardiovascular Study families). The family-based analysis revealed that the minor allele of rs10845493 clustered with elevated LDL-C in offspring more frequently than expected by chance (P=0.0053). The quantitative analysis restricted to subjects free of lipid-lowering treatment confirmed the association between rs10845493 and age-, sex-, and BMI-adjusted circulating levels of LDL-C in families as well as 2 additional populations - 218 unrelated subjects from Silesian Cardiovascular Study replication panel and 1138 individuals from Young Men Cardiovascular Association cohort (P=0.0268, P=0.0476, and P=0.0472, respectively). In the inverse variance weighted meta-analysis of the 3 populations each extra minor allele copy of rs10845493 was associated with 0.14 mmol/L increase in age-, sex-, and BMI-adjusted LDL-C (SE=0.05, P=0.0038).
CONCLUSIONS: Common polymorphism in the gene underlying monogenic form of coronary artery disease impacts on risk of LDL-C elevation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19667113      PMCID: PMC2814817          DOI: 10.1161/ATVBAHA.109.185355

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  30 in total

1.  Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics.

Authors:  Steve Horvath; Xin Xu; Stephen L Lake; Edwin K Silverman; Scott T Weiss; Nan M Laird
Journal:  Genet Epidemiol       Date:  2004-01       Impact factor: 2.135

2.  Essential hypertension and beta2-adrenergic receptor gene: linkage and association analysis.

Authors:  Maciej Tomaszewski; Nick J R Brain; Fadi J Charchar; William Y S Wang; Beata Lacka; Sandosh Padmanabahn; James S Clark; Niall H Anderson; Helen V Edwards; Ewa Zukowska-Szczechowska; Wladyslaw Grzeszczak; Anna F Dominiczak
Journal:  Hypertension       Date:  2002-09       Impact factor: 10.190

3.  A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other.

Authors:  Dale R Nyholt
Journal:  Am J Hum Genet       Date:  2004-03-02       Impact factor: 11.025

4.  Efficiency and power in genetic association studies.

Authors:  Paul I W de Bakker; Roman Yelensky; Itsik Pe'er; Stacey B Gabriel; Mark J Daly; David Altshuler
Journal:  Nat Genet       Date:  2005-10-23       Impact factor: 38.330

5.  Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix.

Authors:  J Li; L Ji
Journal:  Heredity (Edinb)       Date:  2005-09       Impact factor: 3.821

6.  Family-based association between Alzheimer's disease and variants in UBQLN1.

Authors:  Lars Bertram; Mikko Hiltunen; Michele Parkinson; Martin Ingelsson; Christoph Lange; Karunya Ramasamy; Kristina Mullin; Rashmi Menon; Andrew J Sampson; Monica Y Hsiao; Kathryn J Elliott; Gonül Velicelebi; Thomas Moscarillo; Bradley T Hyman; Steven L Wagner; K David Becker; Deborah Blacker; Rudolph E Tanzi
Journal:  N Engl J Med       Date:  2005-03-03       Impact factor: 91.245

7.  Association of the human Y chromosome with cholesterol levels in the general population.

Authors:  Fadi J Charchar; Maciej Tomaszewski; Beata Lacka; Jaroslaw Zakrzewski; Ewa Zukowska-Szczechowska; Wladyslaw Grzeszczak; Anna F Dominiczak
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-12-18       Impact factor: 8.311

Review 8.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

Authors:  Scott M Grundy; James I Cleeman; C Noel Bairey Merz; H Bryan Brewer; Luther T Clark; Donald B Hunninghake; Richard C Pasternak; Sidney C Smith; Neil J Stone
Journal:  Circulation       Date:  2004-07-13       Impact factor: 29.690

9.  Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

Authors:  J Stamler; D Wentworth; J D Neaton
Journal:  JAMA       Date:  1986-11-28       Impact factor: 56.272

10.  Epistatic interaction between beta2-adrenergic receptor and neuropeptide Y genes influences LDL-cholesterol in hypertension.

Authors:  Maciej Tomaszewski; Fadi J Charchar; Beata Lacka; Ullamari Pesonen; William Y S Wang; Ewa Zukowska-Szczechowska; Wladyslaw Grzeszczak; Anna F Dominiczak
Journal:  Hypertension       Date:  2004-09-13       Impact factor: 10.190

View more
  24 in total

1.  Distribution of the number of false discoveries in large-scale family-based association testing with application to the association between PTPN1 and hypertension and obesity.

Authors:  Wen-Chang Wang; Chao A Hsiung; Lan-Chao Wang; Lee-Ming Chuang; Thomas Quertermous; I-Shou Chang
Journal:  Hum Genet       Date:  2010-12-29       Impact factor: 4.132

2.  Low density lipoprotein receptor related protein 1 and 6 gene variants and ischaemic stroke risk.

Authors:  A M Harriott; M G Heckman; S Rayaprolu; A I Soto-Ortolaza; N N Diehl; T Kanekiyo; C-C Liu; G Bu; R Malik; J W Cole; J F Meschia; O A Ross
Journal:  Eur J Neurol       Date:  2015-05-29       Impact factor: 6.089

Review 3.  The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue.

Authors:  Gwang-Woong Go; Roshni Srivastava; Antonio Hernandez-Ono; Gyoungok Gang; Stephen B Smith; Carmen J Booth; Henry N Ginsberg; Arya Mani
Journal:  Cell Metab       Date:  2014-02-04       Impact factor: 27.287

4.  Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes.

Authors:  Soohyun P Kim; Julie L Frey; Zhu Li; Priyanka Kushwaha; Meredith L Zoch; Ryan E Tomlinson; Hao Da; Susan Aja; Hye Lim Noh; Jason K Kim; Mehboob A Hussain; Daniel L J Thorek; Michael J Wolfgang; Ryan C Riddle
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-11       Impact factor: 11.205

5.  Mutation of miR-21 targets endogenous lipoprotein receptor-related protein 6 and nonalcoholic fatty liver disease.

Authors:  Chang-Ping Li; Hong-Jue Li; Jiao Nie; Xia Chen; Xian Zhou
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

6.  LRP6 protein regulates low density lipoprotein (LDL) receptor-mediated LDL uptake.

Authors:  Zhi-jia Ye; Gwang-Woong Go; Rajvir Singh; Wenzhong Liu; Ali Reza Keramati; Arya Mani
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

Review 7.  The role of Lrp5/6 in cardiac valve disease: LDL-density-pressure theory.

Authors:  Nalini M Rajamannan
Journal:  J Cell Biochem       Date:  2011-09       Impact factor: 4.429

8.  Pathway analysis shows association between FGFBP1 and hypertension.

Authors:  Maciej Tomaszewski; Fadi J Charchar; Christopher P Nelson; Timothy Barnes; Matthew Denniff; Michael Kaiser; Radoslaw Debiec; Paraskevi Christofidou; Suzanne Rafelt; Pim van der Harst; William Y S Wang; Christine Maric; Ewa Zukowska-Szczechowska; Nilesh J Samani
Journal:  J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 10.121

Review 9.  Lipoprotein receptor signalling in atherosclerosis.

Authors:  Chieko Mineo
Journal:  Cardiovasc Res       Date:  2020-06-01       Impact factor: 10.787

Review 10.  The interplay of canonical and noncanonical Wnt signaling in metabolic syndrome.

Authors:  Maen D Abou Ziki; Arya Mani
Journal:  Nutr Res       Date:  2018-07-04       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.